Skip to main content

Home/ health information/ Group items tagged LEE

Rss Feed Group items tagged

pharmacybiz

Unveiling the UK's ADHD Medication Crisis: Lee's Struggle - 0 views

  •  
    The severity of the ADHD medication shortage in the UK has been exposed as former Hollywood extra Lee Cato revealed that he was forced to quit his job but hasn't been able to access his medicine. A resident of Berkhamsted, Hertfordshire, Lee had worked as a film extra in big movies like 'Thor' and 'Edge of Tomorrow'. The 48-year-old told Mirror that he has been taking Concerta for years to manage ADHD symptoms, but he hasn't been able to get the drug or any alternatives for over a month. He said that he first experienced shortages of the medicine in December 2023 but was initially able to take Delmosart, which he took to maintain focus despite experiencing its side effects such as headaches, nausea, tooth erosion, and a dry mouth. But now, he can't get access to any of these ADHD drugs as "they're completely out-of-stock and it's been over a month now." His chemist also tried to get hold of his medication but failed.
arunaraayala

Samsung Heir Quizzed As Suspect In Park Geun-Hye Scandal | Locality News - 0 views

  •  
    president of Samsung Electronics and son of Samsung group president Lee Kun-Hee, was due to be questioned on allegations of corruption, prosecutors said on Wednesday.
Ear Doc

New Medical Device for Ear Pain - Medical Matters Asia - 0 views

  •  
    For years, eleven-year-old Lee Jorbin suffered with chronic, painful earache. Recently, she began using a new Israeli device, EarDoc, which releases air and fluids trapped inside the ear, rapidly curing inflammation.
pharmacybiz

Community Pharmacy Overlooked During Pandemic, NPA Tells UK Covid-19 Inquiry - 0 views

  •  
    At the UK Covid-19 Inquiry's Module 3 hearings on 10 September, the National Pharmacy Association (NPA) highlighted that community pharmacy was "often overlooked and under-recognised" during the pandemic. Lawyer Lee John-Charles, speaking on behalf of the NPA, told the Inquiry that despite the central role played by community pharmacy in the delivery of NHS care throughout the pandemic, community pharmacists and their teams were "not given comparable treatment to other frontline healthcare workers." The NPA criticised the initial exclusion of pharmacy workers from the Life Assurance Scheme for frontline workers in England, calling on the Inquiry to investigate this notable omission. The NPA also pointed out that community pharmacies were forced to source and fund their own personal protective equipment (PPE) as it was not initially available to them through the NHS.
pharmacybiz

Groundbreaking Lung Cancer Vaccine Trial Begins at UCLH | Pioneering UK Immunotherapy R... - 0 views

  •  
    A groundbreaking immunotherapy for non-small cell lung cancer (NSCLC) is being trialed in the UK for the first time, with the NIHR UCLH Clinical Research Facility (CRF) as the lead research site. Developed by German biotech firm BioNTech, the new vaccine, named BNT116, can prime the immune system to recognise and combat cancer cells. Janusz Racz, a 67-year-old lung cancer patient from London, was the first participant to receive this new vaccine. According to Siow Ming Lee, a UCLH consultant medical oncologist who is leading the national study, lung cancer remains the leading cause of cancer deaths worldwide, with an estimated 1.8 million deaths reported in 2020 "We are now entering this very exciting new era of mRNA-based immunotherapy clinical trials to investigate the treatment of lung cancer," he said. Supported by the NIHR Biomedical Research Centre at UCLH, the study aims to evaluate the safety and tolerance of the immunotherapy, its efficacy in targeting tumours on its own, and its potential to enhance the effectiveness of established chemotherapy or immunotherapy treatments.
pharmacybiz

Drug shortage: Fixing the medicines shortage crisis - 0 views

  •  
    From over-the-counter flu tablets to crucial antibiotics and antidepressants, medicines are running scarce in UK pharmacies this year, causing concerns among patients, the government, and the wider pharma industry. Drug shortages have accelerated over the past year due to a clutch of problems including the after-effects of the pandemic on supply chains, the war in Ukraine, and soaring input costs weighing on manufacturers. More recently, a sudden spike in respiratory infections - another by-product of Covid-19 that neither pharma companies nor the government were able to predict - has deepened the crisis, with 70 commonly taken drugs out of stock in Britain as of February. The problem is not unique to the UK. In a recent survey of groups representing pharmacies in 29 European countries, three quarters said shortages were worse this winter than a year ago, with a quarter reporting more than 600 drugs in short supply. The US is also facing significant shortages of popular prescription drugs like amoxicillin and Adderall, an ADHD medication. To some extent, the current disruption is laying bare wider challenges facing the industry for several years that were only exacerbated by the pandemic. The over-reliance on foreign suppliers for most active pharmaceutical ingredients (APIs) is one of them. This model has left companies more susceptible to supply shocks, which have in turn increased in frequency and severity due to pandemic lockdowns, the war in Ukraine and other issues such as the shortage of shipping containers. Pharma's long and opaque supply chains, alongside regulatory complexities, also mean it is taking longer for drugmakers to reconfigure manufacturing and distribution in times of additional need.
1 - 6 of 6
Showing 20 items per page